FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission.

about

FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission.

Item

http://www.wikidata.org/entity/Q52902952

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

FLT3-ITD mutations do not impa ...... s in first complete remission.

@en

FLT3-ITD mutations do not impa ...... s in first complete remission.

@nl

type

Item

label

FLT3-ITD mutations do not impa ...... s in first complete remission.

@en

FLT3-ITD mutations do not impa ...... s in first complete remission.

@nl

prefLabel

FLT3-ITD mutations do not impa ...... s in first complete remission.

@en

FLT3-ITD mutations do not impa ...... s in first complete remission.

@nl

P1476

FLT3-ITD mutations do not impa ...... s in first complete remission.

@en

P2093

Anne-Pascale Grandjean

http://www.w3.org/2001/XMLSchema#string

Audrey Simon

http://www.w3.org/2001/XMLSchema#string

Carole Dantin

http://www.w3.org/2001/XMLSchema#string

Eddy Roosnek

http://www.w3.org/2001/XMLSchema#string

Olga Tsopra

http://www.w3.org/2001/XMLSchema#string

Stavroula Masouridi-Levrat

http://www.w3.org/2001/XMLSchema#string

Yan Beauverd

http://www.w3.org/2001/XMLSchema#string

Yordanka Tirefort

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.

Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.

Is allogeneic transplantation really the best treatment for FLT3/ITD-positive acute myeloid leukemia? A systematic review.

Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion.

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial.

Risk and prognostic factors for acute GVHD based on NIH consensus criteria.

P304

392-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HON.2272

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yves Chalandon

P577

2015-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26563907

http://www.w3.org/2001/XMLSchema#string